Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Guggenheim Upgrades Okta to Neutral

Guggenheim Upgrades Okta to Neutral

Guggenheim analyst John Difucci upgrades Okta (NASDAQ:OKTA) from Sell to Neutral.

byBenzinga Newsdesk

September 2, 2022

1 minute read

Guggenheim analyst John Difucci upgrades Okta (NASDAQ:OKTA) from Sell to Neutral.

HC Wainwright & Co. Reiterates Neutral on Albireo Pharma, Maintains $42 Price Target

By Benzinga Newsdesk

February 15, 5:55 AM

HC Wainwright & Co. analyst Ed Arce reiterates Albireo Pharma (NASDAQ:ALBO) with a Neutral and maintains $42 price target.

ALBO

Health Insurer Centene Streamlines – Plans Massive Layoffs To Cut Costs: Report

By Nabaparna Bhattacharya

September 27, 6:49 AM

Centene Corporation (NYSE: CNC) is reportedly laying off about 3% of its workforce as the health insurer plans to cut expenditures and accelerate profits over the years.

CNC

Senator Warren Says Should Reexamine $250,000 Limit On Deposit Insurance; Says Need Similar Deposit Insurance Cap For Small Businesses Or Nonprofits

By Benzinga Newsdesk

March 15, 10:38 AM

-Reuters

SPY

Why Ark’s Cathie Wood Expects Innovation To Prevail As Fed Nears End Of ‘Most Brutal Rate Hike Increase In History’

By Adam Eckert

February 27, 3:40 PM

Ark Invest founder and CEO Cathie Wood is off to a quick start in 2023 with several high-growth names leading the rally to start the year.

ARKK

Guggenheim Upgrades Okta to Neutral

Related Posts

HC Wainwright & Co. Reiterates Neutral on Albireo Pharma, Maintains $42 Price Target

Health Insurer Centene Streamlines – Plans Massive Layoffs To Cut Costs: Report

Senator Warren Says Should Reexamine $250,000 Limit On Deposit Insurance; Says Need Similar Deposit Insurance Cap For Small Businesses Or Nonprofits

Why Ark’s Cathie Wood Expects Innovation To Prevail As Fed Nears End Of ‘Most Brutal Rate Hike Increase In History’